Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation

European Journal of Cardio-thoracic Surgery

Volumn 27, Issue 4, 2005, Pages 554-560

  Meyer, Steven R ^a,c   Campbell, Patricia M ^a   Rutledge, Jennifer M ^b   Halpin, Anne M ^a   Hawkins, Lois E ^b   Lakey, Jonathan R T ^a   Rebeyka, Ivan M ^a   Ross, David B ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b STOLLERY CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Allograft tissue; Hypoplastic left heart syndrome; Panel reactive antibody; Transplantation

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

AGE DISTRIBUTION; ALLOGRAFT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; BLOOD DONOR; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENDER; GRAFT PRESERVATION; GREAT VESSELS TRANSPOSITION; HEART TRANSPLANTATION; HLA TYPING; HUMAN; HUMAN TISSUE; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ANTIBODY SPECIFICITY; AORTA, THORACIC; CHILD; CHILD, PRESCHOOL; CRYOPRESERVATION; FEMALE; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; ISOANTIBODIES; MALE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; PULMONARY ARTERY;

EID: 15744393213     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.12.033     Document Type: Conference Paper

References (25)

1. T. Azakie, S.L. Merklinger, B.W. McCrindle, G.S. Van Arsdell, K.J. Lee, L.N. Benson, J.G. Coles, and W.G. Williams Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience Ann Thorac Surg 72 2001 1349 1353
2. R.J. Baskett, D.B. Ross, M.A. Nanton, and D.A. Murphy Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity? J Thorac Cardiovasc Surg 112 1996 1170 1178
3. M.J. Welters, F.B. Oei, L.M. Vaessen, A.P. Stegmann, A.J. Bogers, and W. Weimar Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation Clin Exp Immunol 124 2001 353 358
4. J.F. Legare, T.D. Lee, K. Creaser, and D.B. Ross T lymphocytes mediate leaflet destruction and allograft aortic valve failure in rats Ann Thorac Surg 70 2000 1238 1245
5. M.K. Green, M.D. Walsh, A. Dare, P.G. Hogan, X.M. Zhao, I.H. Frazer, A.S. Bansal, and M.F. O'Brien Histologic and immunohistochemical responses after aortic valve allografts in the rat Ann Thorac Surg 66 1998 S216 S220
6. S. Itescu, T. Tung, E. Burke, A. Weinberg, N. Moazami, J. Artrip, N. Sucia-Foca, E. Rose, M. Oz, and R. Michler Preformed IgG antibodies against major histocompatibility class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation Circulation 98 1998 786 793
7. A.R. Tambur, R.A. Bray, S.K. Takemoto, M. Mancini, M.R. Costanzo, J.A. Kobashigawa, C.L. D'Amico, K.R. Kanter, A. Berg, J.D. Vega, A.L. Smith, A.L. Roggero, J.W. Ortegel, L. Wilmoth-Hosey, J.M. Cecka, and H.M. Gebel Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection Transplantation 70 2000 1055 1059
8. R.H. Kerman, B. Susskind, D. Kerman, M. Lam, K. Gerolami, J. Williams, R. Kalish, M. Campbell, S. Katz, C.T. Van Buren, H. Frazier, B. Radovancevic, S. Fife, and B. Kahan Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease J Heart Lung Transplant 17 1998 789 794
9. J.S. Thompson, L.R. Thacker 2nd, and S. Takemoto The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry Transplantation 69 2000 2178 2186
10. J.P. Jacobs, J.A. Quintessenza, R.J. Boucek, V.O. Morell, L.M. Botero, V. Badhwar, H.M. van Gelder, A. Asante-Korang, J. McCormack, and G.R. Daicoff Pediatric cardiac transplantation in children with high panel reactive antibody Ann Thorac Surg 78 2004 1703 1709
11. R.J. Baskett, M.A. Nanton, A.E. Warren, and D.B. Ross Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions J Thorac Cardiovasc Surg 126 2003 232 239
12. G. Pompilio, G. Polvani, G. Piccolo, A. Guarino, A. Nocco, A. Innocente, M. Porqueddu, L. Dainese, F. Veglia, A. Sala, and P. Biglioli Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: Implications with valve dysfunction Ann Thorac Surg 78 2004 557 563
13. F.B. Oei, M.J. Welters, C.J. Knoop, L.M. Vaessen, A.P. Stegmann, W. Weimar, and A.J. Bogers Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients Eur J Cardiothorac Surg 18 2000 466 472
14. S.H. Leech, S. Rubin, H.J. Eisen, P.J. Mather, B.I. Goldman, J.B. McClurken, and S. Furukawa Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients Clin Transplant 17 2003 17 26
15. P. Hogan, L. Duplock, M. Green, S. Smith, K.L. Gall, I.H. Frazer, and M.F. O'Brien Human aortic valve allografts elicit a donor-specific immune response J Thorac Cardiovasc Surg 112 1996 1260 1266
16. F.M. Hoekstra, M. Witvliet, C.Y. Knoop, C. Wassenaar, A.J. Bogers, W. Weimar, and F.H. Claas Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies Ann Thorac Surg 66 1998 2022 2026
17. J.D. Smith, H. Ogino, D. Hunt, R.M. Laylor, M.L. Rose, and M.H. Yacoub Humoral immune response to human aortic valve homografts Ann Thorac Surg 60 1995 S127 S130
18. J.A. Hawkins, J.P. Breinholt, L.M. Lambert, T.C. Fuller, T. Profaizer, E.C. McGough, and R.E. Shaddy Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients J Thorac Cardiovasc Surg 119 2000 324 330
19. G.E. Rodey, J.F. Neylan, J.D. Whelchel, K.W. Revels, and R.A. Bray Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private vs. public specificities in potential transplant recipients Hum Immunol 39 1994 272 280
20. M.A. Blajchman Immunomodulation and blood transfusion Am J Ther 9 2002 389 395
21. R.E. Shaddy, T.C. Fuller, J.B. Anderson, L.M. Lambert, M.K. Brinkman, T. Profaizer, and J.A. Hawkins Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation Ann Thorac Surg 77 2004 1734 1739
22. J.A. Hawkins, N.D. Hillman, L.M. Lambert, J. Jones, G.B. Di Russo, T. Profaizer, T.C. Fuller, L.L. Minich, R.V. Williams, and R.E. Shaddy Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts J Thorac Cardiovasc Surg 126 2003 247 252
23. P.G. Hogan, and M.F. O'Brien Improving the allograft valve: does the immune response matter? J Thorac Cardiovasc Surg 126 2003 1251 1253
24. D.C. Drinkwater Jr, A.S. Aharon, S.V. Quisling, D. Dodd, V.S. Reddy, A. Kavanaugh-McHugh, T. Doyle, N.R. Patel, F.E. Barr, J.K. Kambam, T.P. Graham, and P.A. Chang Modified Norwood operation for hypoplastic left heart syndrome Ann Thorac Surg 72 2001 2081 2086
25. K. Ishino, O. Stumper, J.J. De Giovanni, E.D. Silove, J.G. Wright, B. Sethia, W.J. Brawn, and M. de Leval The modified Norwood procedure for hypoplastic left heart syndrome: early to intermediate results of 120 patients with particular reference to aortic arch repair J Thorac Cardiovasc Surg 117 1999 920 930